Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells

Measles Virus Vaccine-Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells

(2013) J.-B. Guillerme et al.   CLINICAL CANCER RESEARCH

Harnessing human plasmacytoid dendritic cells as professional APCs

(2012) Jurjen Tel et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Interferon-α as Antiviral and Antitumor Vaccine Adjuvants: Mechanisms of Action and Response Signature

(2012) Eleonora Aricò et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Oncolytic virotherapy

(2012) Stephen J Russell et al.   NATURE BIOTECHNOLOGY

Measles virus causes immunogenic cell death in human melanoma

(2011) O G Donnelly et al.   GENE THERAPY

Measles Virus Induces Oncolysis of Mesothelioma Cells and Allows Dendritic Cells to Cross-Prime Tumor-Specific CD8 Response

(2008) A. Gauvrit et al.   CANCER RESEARCH